Characterizing NSCLC tumor microenvironment using the integrated MultiOmyx-RNAscope assay

Subject:

Co-detection of a tumor-infiltrating lymphocyte immunofluorescence (IF) panel and cytokine RNA in-situ hybridization (ISH) markers in non-small cell lung cancer tumor microenvironment using combined MultiOmyx™ and RNAscope™ platforms.

Areas covered:

Co-detection of RNA and protein provides critical information such as the source of secreted proteins (e.g. cytokines) or cell-type specific transcript levels

The novel integrated RNAscope™ – MultiOmyx™ IF assay is a robust and sensitive platform for simultaneous detection of multiple RNA and protein biomarkers<

This integrated approach is shown to spatially correlate the distribution of cytokine RNA expression in immune cell subsets within the tumor microenvironment of NSCLC samples

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients